Mental Health Clinics in Carterville, IL Accepting Medicare
10 Mental Health Clinics found. Showing 1 - 10
 Shawnee Health Social Services Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 6355 Brandhorst Rd, Carterville, IL 62918 Phone: 618-519-9200 Fax: 618-985-9096 |
Centerstone Of Illinois, Inc Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 403 Municipal Dr, Carterville, IL 62918 Phone: 855-608-3560 |
Solutions Counseling & Education Inc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 209 W Commercial Dr, Suite H, Carterville, IL 62918 Phone: 618-985-1072 Fax: 618-985-1076 |
Centerstone Of Illinois, Inc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 403 Municipal Dr, Carterville, IL 62918 Phone: 618-937-6483 |
Carbondale Counseling Associates Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 209 W Commercial Dr Ste H, Carterville, IL 62918 Phone: 618-351-9700 Fax: 618-351-9701 |
Shawnee Health Service And Development Corp Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 109 California St, Carterville, IL 62918 Phone: 618-985-8221 Fax: 618-985-6860 |
The H Group Bbt, Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1006 S Division St, Carterville, IL 62918 Phone: 618-937-6483 |
Centerstone Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 310 W Plaza Dr, Carterville, IL 62918 Phone: 618-937-6483 |
Centerstone Of Illinois Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 402 E Plaza Dr Ste 5, Carterville, IL 62918 Phone: 618-937-6483 |
The H Group Bbt Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 403 Commerce Drive, Carterville, IL 62918 Phone: 618-937-6483 |
News Archive
FDA gives tentative approval for generic pediatric AIDS drug
The Food and Drug Administration (FDA) today announced the tentative approval of the generic version of Abacavir Sulfate Oral Solution.
Novel drug combats psychosis in Parkinson's disease
The non-dopaminergic drug pimavanserin reduces psychotic symptoms in patients with Parkinson's disease without worsening motor function, shows a randomized trial.
SPECT imaging may not be suitable for monitoring Parkinson's disease, study shows
When monitoring Parkinson's disease, SPECT imaging of the brain is used for acquiring information on the dopamine activity. A new study conducted in Turku, Finland, shows that the dopamine activity observed in SPECT imaging does not reflect the number of dopamine neurons in the substantia nigra, as previously assumed.
The role of micro-RNA in SARS-CoV-2 infection and COVID-19
A team of researchers based in Iran have explored the role of micro-RNA in COVID-19. Their study titled, "The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection," was published in the latest issue of the journal International Immunopharmacology.
Study: Certain characteristics can lead to therapy-related leukemia in breast cancer survivors
A new analysis indicates that certain characteristics may increase a breast cancer survivor's risk of developing leukemia after undergoing chemotherapy and/or radiation. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings are a first step toward finding ways to prevent this serious and potentially life-threatening treatment-related complication.
› Verified 2 days ago